Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-03-16 | Michael R. Holmes has been a director of the Company since 2015. The Compensation Committee consists of Directors DeCola (Committee Chairman), Eulich, Holmes, Mullins, and Murphy. |
| 2017-03-15 | Michael R. Holmes has been a director of the Company since 2015. Since February 2016, he has served as Chairman of the Board for Rx Outreach, Inc. ... The Compensation Committee consisted of Directors DeCola (Chairman), Eulich, Holmes, and Murphy. ... The following table sets forth compensation paid to each of the Company’s non-employee directors during 2016. ... Michael R. Holmes $27 Fees Earned or Paid in Cash, $42,973 Stock Awards, Total $43,000. |
| 2018-03-14 | The Executive Committee is empowered to act on behalf of, and to exercise the powers of, the full Board of Directors in the management of the business and affairs of the Company when the full Board is not in session, except to the extent limited by applicable Delaware law. The charter for the Executive Committee may be found in the investor relations section of the Company’s website at www.enterprisebank.com. All actions by the Executive Committee are reported at the next regular Board of Directors meeting. In addition, approved Executive Committee minutes are shared with all directors. In 2017, the committee met one time. All members of the Executive Committee meet the NASDAQ independence standards. The Committee consists of five members: Directors Eulich, (Committee Chairperson), Guest, Heeter, Holmes, and Van Trease. In 2017, non-employee directors received a $30,000 annual retainer, with Mr. Eulich receiving an $85,000 retainer for his service as chairperson of the Board and Executive Committee. Annual retainers are paid in July of each year for the upcoming 12 month period. Additionally, members receive $1,250 per board meeting attended. For committee service, the Chairpersons received an additional retainer as follows: Audit Committee - $10,000, Compensation Committee - $8,000, Risk Committee - $8,000 and Nominating and Governance Committee - $6,000. Non-Chairperson committee members receive $1,000 per committee meeting attended. Directors also receive attendance fees and retainers for service on the Bank's Board of Directors and for representing the holding company board on other committees and advisory boards. In 2017, Mr. Arnold and Mr. Eulich received cash fees of $19,500 and $14,500, respectively, for their services on the Bank's board of directors. Ms. Schmitz and Mr. Guest received a stipend of $950 and $10,200, respectively, for their service on Advisory Boards. Directors elect whether to receive their holding company board compensation in 100% common stock or 50% cash / 50% common stock. Shares are granted and issued on the cash payment date and are calculated using the grant date fair value. Such shares are not subject to vesting requirements. The shares are issued under the stockholder approved Stock Plan for Non-Management Directors. Michael R. Holmes received total annual compensation of $43,500 in 2017. |
| 2019-04-17 | Michael R. Holmes has served as Chairperson of the Board for Rx Outreach, Inc., since February 2016. Rx Outreach, Inc. is a non-profit pharmacy that dispenses more than 30,000 months of medicine each week to low income individuals across the United States. Previously, he served as President of Rx Outreach, Inc. from October 2010 through January 2016. Prior to that, he served as Executive Vice President of Express Scripts from December 2005 through October 2010, responsible for Corporate Strategy, Research and Clinical Services, Human Resources, Corporate Real Estate, Security, Procurement, and all of its domestic subsidiary businesses. Mr. Holmes has broad public company senior management experience as well as consumer, financial and investment expertise. Mr. Holmes also brings to the Board a valuable perspective on community engagement and underserved markets. |
| 2020-03-25 | In 2019, the Compensation Committee consisted of Directors Holmes (Committee Chairperson), DeCola, Eulich, Kent, and Van Trease. |
| 2021-03-17 | In 2020, all members of the Executive Committee meet the Nasdaq independence standards. In 2020, Directors Eulich (Committee Chairperson), Guest, Heeter, and Van Trease served on the Committee for the full year. Directors Holmes (from January through May) and DeCola (from May through year end) served on the Committee for a portion of the year...In 2020, the Nominating and Governance Committee consisted of Directors Heeter (Committee Chairperson), DeCola, Guest, Havel, and Holmes for the full year...In 2020, the Compensation Committee consisted of Directors DeCola (Committee Chairperson), Eulich, Holmes, Kent, Scavuzzo, and Van Trease. Director Holmes previously served as the Compensation Committee Chairperson until May 2020 when Director DeCola was appointed to the Chairperson position...Michael R. Holmes total annual compensation was $67,250. |
| 2022-03-22 | Michael R. Holmes has served as Chairperson Emeritus of the Board for Rx Outreach, Inc., since May 2020, having previously served as Chairperson of the Board of Rx Outreach, Inc. since February 2016. Rx Outreach, Inc. is a non-profit pharmacy that dispenses more than 30,000 months of medicine each week to low income individuals across the United States. Previously, he served as President of Rx Outreach, Inc. from October 2010 through January 2016. Prior to that, he served as Executive Vice President of Express Scripts from December 2005 through October 2010, responsible for Corporate Strategy, Research and Clinical Services, Human Resources, Corporate Real Estate, Security, Procurement, and all of its domestic subsidiary businesses. Mr. Holmes has broad public company senior management experience as well as consumer, financial and investment expertise. Mr. Holmes also brings to the Board a valuable perspective on community engagement and underserved markets. |
| 2023-03-29 | Michael R. Holmes has served as Chairperson Emeritus of the Board for Rx Outreach, Inc. ... In 2022, Directors Eulich (Committee Chairperson), DeCola, Guest, and Van Trease served on the Executive Committee ... The Nominating and Governance Committee consisted of Directors DeCola (Chairperson as of May 2022), Guest, and Holmes ... The Compensation Committee consisted of Directors Holmes (Committee Chairperson as of May 2022), DeCola (Chairperson from January through May 2022) ... Director Compensation table shows Michael R. Holmes total annual compensation as $104,500. |
| 2024-03-19 | In 2023, the Compensation Committee consisted of Directors Holmes (Committee Chairperson), DeCola, Holmes, Kent, and Van Trease. ... In 2023, Directors DeCola (Committee Chairperson), Guest, Holmes, and Van Trease served on the Executive Committee. ... In 2023, the Nominating and Governance Committee consisted of Directors Van Trease (Chairperson), DeCola, Guest, Holmes, and Schmitz. ... The following table sets forth compensation paid to each of the Company’s non-employee directors during 2023. Michael R. Holmes: Total Annual Compensation $138,000. |
| 2025-03-26 | In 2024, the Human Capital and Compensation Committee consisted of Directors Holmes (Committee Chairperson), Andrich, DeCola, Kent, and Van Trease for the full year. ... Director DeCola is the current Chairperson of the Board and has held that position since May 2023. ... In 2024, Directors DeCola (Committee Chairperson), Guest, Holmes, Kent and Van Trease served on the Executive Committee for the full year. ... The following table sets forth compensation paid to each of the Company’s non-employee directors during 2024. Michael R. Holmes: Total Annual Compensation $130,000. |
Data sourced from SEC filings. Last updated: 2026-03-05